Dr. Ruth Gilboa, MD

Dr. Gilboa practices at Dermatology Specialists Inc in Oceanside, California.

Dr. Gilboa's NPI, 1205873197, was assigned on June 1, 2006. Dr. Gilboa graduated from Lund University Faculty of Medicine in 1977. Dr. Gilboa holds California license A46557.

Dr. Gilboa's primary practice is Dermatology Specialists Inc, at 3629 Vista Way, Oceanside, CA 92056 in San Diego County. The practice phone is (760) 828-9200.

Dr. Gilboa's primary practice is Dermatology Specialists Inc in Oceanside, California. The medical group on file is Dermatology Specialists, Inc. Dmand AI also links Dr. Gilboa to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilboa practices. Vendor and product names are available with a free account.

Dermatology is Dr. Gilboa's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gilboa is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, itchy rashes and joint cyst among the conditions Dr. Gilboa treats.

CMS data shows 3,859 Medicare services from Dr. Gilboa across 18 procedure codes in 2024, for 362 Medicare patients. Medicare paid $160,033 for them. Every service was in an office.

CMS counts 362 Medicare patients who saw Dr. Gilboa in 2024. The largest group is 65 to 74, with 196 patients. 68% of them have high cholesterol, and 52% have high blood pressure. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gilboa's median patient age at 69, with 58% women.

In 2024, Dr. Gilboa wrote 420 Medicare Part D claims for 213 patients. 93% of them were for generic drugs. CMS names the drug for 330 of them, across 11 drugs with 11 or more claims each, at $12,983 in total drug cost. In 2023, CMS named 276 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Gilboa for performance year 2024, reported as part of a group. Dr. Gilboa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 895 procedures of removal of skin lesions by Dr. Gilboa, more than 92% of the clinicians it reports for that procedure.

Dmand AI links Dr. Gilboa to 1 clinical trial. Conditions studied include Dermatitis, Atopic and Skin Diseases, Eczematous. Open Payments lists research payments to Dr. Gilboa that name 1 trial.

CMS Open Payments shows 656 general payments to Dr. Gilboa from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Valeant Pharmaceuticals International paid the most, $3,026. It also lists 13 research payments totaling $2,175 from 2016 to 2019, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Gilboa, most recently CMS Stage 1 EHR in 2013.

Dr. Gilboa graduated from Lund University Faculty of Medicine in 1977. Dr. Gilboa is a member of AAD and ASDS.

Dr. Gilboa is in network with 16 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.